Is melatonin safe? For most adults, short-term use appears to be, according to the US National Center for Complementary and Integrative Health, and two systematic reviews of controlled trials (50 and 37 trials) found mostly mild effects such as sleepiness and headache. What is missing is long-term data, since most trials ran 4 weeks or less, and clean labeling: in 31 supplements, melatonin content ranged from 83% below to 478% above the stated amount, and 22 of 25 gummies were inaccurately labeled. For pregnancy a 2022 review found 15 human studies and no randomized trial for sleep problems, so ask your doctor or midwife before using it.
Is melatonin safe? It sits on the shelf next to vitamins, which makes it feel like one. It is a hormone, sold in most US stores without a prescription, taken by a growing number of adults every night, and the question of how safe it is does not have one clean answer.
This article sorts the answer by what is known (short-term adult use), what is shaky (the label), and what is genuinely missing (long-term use, pregnancy, children). It gives no dosing advice. For timing and how much trials used, see Melatonin for sleep.
Is melatonin safe? What the safety reviews found
The US National Center for Complementary and Integrative Health states on its melatonin page (opened 2 November 2026) that short-term use "appears to be safe for most people", that information on long-term safety is lacking, and that there is not enough information yet about side effects at doses higher than the body normally makes (nccih.nih.gov). Two systematic reviews of controlled trials back the first half of that statement.
The first looked at 50 controlled studies of oral melatonin in humans that analyzed adverse events statistically. Twenty-six found nothing significant, and 24 found at least one significant adverse event. These were generally minor, short-lived and easily managed, most often fatigue, mood changes, or reduced psychomotor and cognitive performance. A few studies saw changes in blood pressure, heart rate, reproductive hormones and glucose metabolism that seemed to depend on dose, timing and interactions with blood pressure medicines. The reviewers called the profile "generally favourable", with exceptions.
Foley HM, Steel AE. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complement Ther Med 2019. PMID 30670284
The second reviewed 37 placebo-controlled trials in people with sleep disorders, with doses between 0.15 and 12 mg a day. The most frequent complaints were daytime sleepiness (1.66%), headache (0.74%), other sleep-related events, dizziness and hypothermia. Very few events were serious, and none were life threatening. The catch is the follow-up: up to 29 weeks, but most trials lasted 4 weeks or less, and only 8 of the studies were judged "good" on risk of bias. Their conclusion was that the lack of long-term trials limits what can be said about continuous use, and that there were too few robust data to assess risks in groups such as pre-adolescent children and people with epilepsy or asthma.
Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review. CNS Drugs 2019. PMID 31722088
Even the higher-dose literature leans reassuring on the surface. A meta-analysis of randomized trials using 10 mg or more in adults found that in the four trials with low risk of bias, serious adverse events were not detectably increased (rate ratio 0.88, 95% CI 0.52 to 1.50), though drowsiness, headache and dizziness were more frequent (1.40, 1.15 to 1.69). Out of 79 trials with 3,861 participants, 29 did not report on adverse events at all. The authors wrote that their confidence limits were very wide.
Menczel Schrire Z, Phillips CL, Chapman JL, Duffy SL, Wong G, D'Rozario AL, Comas M, Raisin I, Saini B, Gordon CJ, McKinnon AC, Naismith SL, Marshall NS, Grunstein RR, Hoyos CM. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. J Pineal Res 2022. PMID 34923676
Put together: the claim that melatonin is safe holds for short courses in adults who are otherwise well. It is not a statement about years of nightly use, and the trials are not designed to say so.
Is melatonin bad for you? What the long-term and effect-size data say
The claim that melatonin is bad for you usually comes in one of three forms, and the evidence differs for each. The first is harm from taking it. The trials above found mostly minor effects over short courses, and the long-term data are thin. A 2022 review limited to prospective trials of at least six months that recorded adverse events systematically found the reported frequency of possible adverse events low and few that were clinically significant. Its authors still warned that the scarcity of double-blind, randomized, placebo-controlled data should caution against complacency, noting that many children and adolescents now have years of continuous exposure.
Besag FMC, Vasey MJ. Adverse events in long-term studies of exogenous melatonin. Expert Opin Drug Saf 2022. PMID 36562403
The second form is the contents of the bottle, covered in the next section: what is in the capsule can differ a lot from the label. The third is a specific signal, such as the 2025 conference abstract on heart failure in health records, which is an observational association and cannot show cause (see the link below).
What a melatonin supplement for insomnia does is the other half of any risk question. A meta-analysis of 19 randomized placebo-controlled trials with 1,683 adults and children who had primary sleep disorders found that melatonin shortened the time to fall asleep by 7.06 minutes compared with placebo (95% confidence interval 4.37 to 9.75), and also increased total sleep time and improved sleep quality. The authors call the effect modest, smaller than that of other medicines used for insomnia, and note that it did not appear to fade with continued use.
Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One 2013. PMID 23691095
Read together, the data do not show that melatonin is harmful over a short course in adults, and they do not show that a longer habit is harmless either: the benefit is small and the safety record stops at the length of the trials. Long nightly use is worth raising with a doctor or pharmacist who knows your other medicines.
What the bottle may not tell you
A safety review assumes that the capsule contains what the label says. Researchers who tested this measured melatonin in 31 commercial supplements and found content between 83% below and 478% above the labelled amount. The same product could differ by up to 465% from one lot to the next, and more than 71% did not land within 10% of the label. Eight of the supplements, 26%, also contained serotonin, at 1 to 75 micrograms. The variability did not follow brand or product type.
Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med 2017. PMID 27855744
The gummy picture is no better. NCCIH summarizes a 2023 study of 25 over-the-counter gummy products: 22 were inaccurately labeled, one had no detectable melatonin, and the rest ranged from 74% to 347% of the labeled amount, mostly above it. The gummy study tested products sold in the US, where melatonin is regulated as a dietary supplement. The practical point is limited but real: when you read a safety result for "3 mg of melatonin", the pill in your hand may be a different dose.
Is melatonin safe during pregnancy? An evidence gap
The short version of the pregnancy data is that they are sparse. A scoping review searched four databases for human studies of exogenous melatonin in pregnancy and breastfeeding and found 15: eight in pregnancy, seven in breastfeeding. They were a mix of case reports, cohort studies and trials. None of them had insomnia as the main outcome, and there was no randomized trial of melatonin as a sleep treatment in either group. Trials that used melatonin for other conditions did not suggest major safety concerns. Concern about pregnancy comes mainly from animal research, and the review's authors concluded that human studies so far suggest use is "probably safe", while calling for proper studies on sleep disorders. Use in pregnant populations was about 4% in large database surveys.
Vine T, Brown GM, Frey BN. Melatonin use during pregnancy and lactation: A scoping review of human studies. Braz J Psychiatry 2022. PMID 34730672
"Probably safe" from 15 mixed studies is a long way from "tested". NCCIH puts it more bluntly: there has been a lack of research on melatonin in pregnant or breastfeeding women. If you are pregnant, planning a pregnancy or nursing, the useful step is a short conversation with your doctor or midwife before you start. Sleep in pregnancy has its own page: Insomnia in pregnancy.
Children, interactions and a few other groups
Children are the group where the exposure has grown fastest. US poison centers received 260,435 reports of pediatric melatonin ingestions between 2012 and 2021, and the yearly number rose by 530%. By 2021 these made up 4.9% of all pediatric ingestion reports, against 0.6% in 2012. Hospitalizations and serious outcomes rose too, mainly from unintentional ingestions in children aged 5 and under, with five children needing mechanical ventilation and two deaths.
Lelak K, Vohra V, Neuman MI, Toce MS, Sethuraman U. Pediatric Melatonin Ingestions - United States, 2012-2021. MMWR Morb Mortal Wkly Rep 2022. PMID 35653284
Older adults are a third group. In 27 people with insomnia complaints and low natural melatonin, a combined immediate and slow-release product at 4 mg kept blood levels above 50 pg/mL for about 10 hours, which the authors flagged as possibly extending beyond the sleep period, and NCCIH notes that the 2015 AASM guidelines recommend against melatonin for people with dementia. Neither point says melatonin is unsafe for an older person. Both say that age changes how long the supplement acts, which is a question for a doctor or pharmacist who knows the rest of the medicine list.
Gooneratne NS, Edwards AY, Zhou C, Cuellar N, Grandner MA, Barrett JS. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults. J Pineal Res 2012. PMID 22348451
Medicine interactions are the other area with concrete data. In a small study of five healthy men, adding 50 mg of the antidepressant fluvoxamine to a 5 mg melatonin dose raised the total exposure 17-fold and the peak 12-fold. That is one drug and five people, but it shows that melatonin levels depend on what else you take.
Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000. PMID 10668847
Blood sugar timing is a smaller example. In 21 healthy young women, 5 mg of melatonin taken 15 minutes before a 75 g glucose drink increased the blood sugar response in the morning (by 186% in the incremental area under the curve) and in the evening (by 54%) compared with placebo. The authors suggest that proximity to meals may need consideration, particularly in people at risk for glucose intolerance.
Rubio-Sastre P, Scheer FA, Gómez-Abellán P, Madrid JA, Garaulet M. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep 2014. PMID 25197811
On heart questions, see Melatonin and heart failure: it covers a 2025 conference abstract that linked long-term use to heart failure in health records, and why it cannot prove cause.
Who the sources say should check first
| Group | What the sources say | Source |
|---|---|---|
| Pregnant or breastfeeding | 15 human studies, no randomized trial for sleep; research lacking | Vine 2022; NCCIH |
| Children | Work with a provider; ingestions by young children rising | NCCIH; Lelak 2022 |
| People with epilepsy or on blood thinners | Need medical supervision when using melatonin | NCCIH |
| People on antidepressants such as fluvoxamine | Melatonin exposure rose 17-fold in one study | Härtter 2000 |
| People with dementia | NCCIH cites 2015 AASM guidelines recommending against use | NCCIH |
| Anyone planning nightly use for months | Long-term safety data lacking | NCCIH; Besag 2019 |
If you need melatonin most nights to sleep at all, that is worth a doctor's visit in itself. Long-lasting insomnia, loud snoring with pauses, or sleepiness during the day can have causes a supplement does not touch.
Where SleepTrace fits
Safety worries tend to grow when you cannot see what your nights look like. SleepTrace listens through the phone's microphone and shows what it heard: snoring, talking and coughing with short clips you can play back, possible breathing pauses marked with a time (no clip), and sleep phases estimated from sound alone. It also gives a sleep apnea indicator as a screening estimate, not a diagnosis. The free plan includes nightly tracking and 3 playable clips a month, on iPhone and Android. It needs the app left open and the phone charging beside you, and the screen dims by itself.
It cannot tell you what a supplement is doing in your body, how much is in the bottle, or whether a medicine interaction matters. What it can give you is a record to bring along: how your nights are going, whether snoring or pauses appear, and whether that changes over a few weeks. That is useful when you ask a doctor or pharmacist whether melatonin fits your situation.
Frequently asked questions
Not enough is known to say. NCCIH writes that short-term use appears safe for most people and that information on long-term safety is lacking. A review of 37 placebo-controlled trials followed people for up to 29 weeks, most for 4 weeks or less, and concluded that this limits what can be said about continuous use over long periods. A 2025 conference abstract linking long-term use to heart failure in health records adds a question, not an answer (see the article on melatonin and heart failure).
The evidence is thin. A 2022 scoping review found 15 human studies (8 in pregnancy, 7 in breastfeeding), no randomized trial of melatonin for sleep problems in either, and no major safety concerns in trials that used melatonin for other conditions. The reviewers called it probably safe in humans while asking for proper studies; NCCIH says research on pregnant and breastfeeding women is lacking. Talk to your doctor or midwife before using it.
Yes. NCCIH says people with epilepsy and those taking blood thinners need to be under medical supervision when using melatonin supplements. In five healthy men, the antidepressant fluvoxamine raised the total exposure to a 5 mg melatonin dose 17-fold. A pharmacist can check your list in a minute.
The concern with gummies is the contents, not the form. A 2023 study cited by NCCIH found 22 of 25 over-the-counter gummy products inaccurately labeled, with melatonin ranging from 74% to 347% of the labeled amount and one product with no detectable melatonin. A 2017 study of 31 supplements of all types found a similar spread.
NCCIH advises working with a health care provider before giving melatonin to a child. US poison centers received 260,435 reports of pediatric melatonin ingestions between 2012 and 2021, a 530% rise in yearly numbers, mostly unintentional ingestions by children aged 5 and under.
The trials do not show that it is over short courses: two reviews of 50 and 37 trials found mostly minor effects such as sleepiness and headache. What is missing is long-term data. A 2022 review of prospective trials of six months or more found few clinically significant adverse events but warned against complacency because double-blind placebo-controlled data are scarce. The benefit is small too: a meta-analysis of 19 trials found 7.06 minutes faster sleep onset than placebo.
Modestly. In 19 randomized placebo-controlled trials with 1,683 adults and children with primary sleep disorders, melatonin shortened the time to fall asleep by 7.06 minutes (95% confidence interval 4.37 to 9.75) and improved sleep quality and total sleep time, and the effect did not appear to fade with continued use. The authors describe it as smaller than the effect of other medicines for insomnia.
SleepTrace is a wellness app, not a medical device. This article is general information, not medical advice. If your symptoms are frequent, severe or worrying, please talk to a doctor.
Whether melatonin is safe for you depends on age, medicines and other conditions, and that conversation belongs to a doctor or pharmacist. SleepTrace records sound only and shows your estimated sleep phases, snoring and possible breathing pauses, so you can describe what your nights are like in that period. It cannot tell you whether the pill is the cause of anything.
Hear your own night. SleepTrace turns a night of audio into your sleep phases, the sounds you made, and how it all trends. Works without a wearable, better with one. Your phone on the nightstand is enough to start. Get it for iPhone or Android →